Bone, Richard

Bone, Richard was paid $28.22M by Medicaid between Jan 2018 and Dec 2024, across 305 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 14% of everything it billed.

Compared with peers

Next to other Gastroenterology Physician providers in Illinois

Rank by total paid#1 of 370

Median peer was paid$16K

This provider vs. median1,751×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	372	$6K
2021	499,937	$9.73M
2022	547,717	$10.25M
2023	469,951	$7.41M
2024incomplete	78,911	$821K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	14%	53,968	50,509	$4.04M
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	6.9%	24,292	22,375	$1.96M
84443	Thyroid stimulating hormone (TSH)	4.8%	84,587	76,974	$1.34M
80053	Comprehensive metabolic panel	4.6%	133,487	119,893	$1.30M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	4.3%	26,630	24,644	$1.21M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	4.2%	26,186	24,314	$1.19M
87481		2.9%	9,584	8,503	$813K
80061	Lipid panel	2.6%	98,190	89,254	$745K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.6%	133,400	120,036	$729K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	2.4%	24,518	21,638	$687K
81513		2.2%	7,376	6,697	$621K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.2%	26,132	25,004	$612K

293 more codes

82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.2%	36,633	$609K
80050	General health panel	2.1%	12,194	$600K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	1.8%	12,284	$510K
83036	Hemoglobin; glycosylated (A1C)	1.6%	77,689	$461K
86480		1.3%	7,226	$367K
0001A		1.2%	8,779	$350K
86803		1.1%	18,801	$308K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.1%	10,618	$299K
0002A		1.1%	7,281	$297K
87563		1.0%	14,318	$294K
91322		1.0%	2,463	$290K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	1.0%	15,742	$286K
87086	Culture, bacterial; quantitative colony count, urine	<1%	27,818	$280K
86003		<1%	3,009	$228K
82607		<1%	17,009	$193K
84439		<1%	22,667	$192K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	3,974	$177K
0124A		<1%	4,165	$164K
82728		<1%	20,221	$160K
86235		<1%	1,914	$160K
83550		<1%	18,874	$154K
80048	Basic metabolic panel (calcium, ionized)	<1%	19,478	$147K
87507		<1%	439	$144K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,620	$139K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,091	$135K
0071A		<1%	3,169	$134K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	388	$129K
87340		<1%	9,598	$126K
82746		<1%	11,350	$123K
82570		<1%	28,324	$122K
83540		<1%	20,001	$121K
0072A		<1%	2,806	$118K
85027		<1%	20,942	$115K
83880		<1%	5,168	$110K
86780		<1%	6,383	$109K
86706		<1%	7,830	$107K
87480		<1%	3,666	$95K
87510		<1%	3,619	$93K
82043		<1%	23,622	$86K
86787		<1%	5,588	$83K
84153		<1%	6,552	$82K
87529		<1%	967	$82K
0054A		<1%	1,921	$79K
83970		<1%	2,862	$78K
86038		<1%	5,141	$78K
0004A		<1%	2,153	$76K
87186		<1%	6,889	$75K
87081		<1%	12,608	$72K
83655		<1%	5,963	$70K
83013		<1%	1,816	$70K
83001		<1%	3,911	$69K
86592		<1%	17,156	$68K
80081		<1%	1,111	$67K
81001		<1%	24,267	$65K
83735		<1%	10,936	$65K
84403		<1%	2,593	$63K
86704		<1%	4,184	$63K
88342		<1%	1,213	$60K
86850		<1%	10,127	$60K
82274		<1%	6,377	$60K
87660		<1%	3,556	$59K
0011A		<1%	1,471	$58K
82105		<1%	3,583	$57K
0012A		<1%	1,380	$57K
86140		<1%	12,328	$55K
82784		<1%	4,109	$54K
0051A		<1%	1,330	$54K
84481		<1%	5,541	$53K
80074		<1%	1,417	$52K
0111A		<1%	1,213	$51K
88341		<1%	714	$50K
86762		<1%	5,608	$48K
84702		<1%	5,416	$48K
0052A		<1%	1,141	$47K
86146		<1%	601	$45K
80076		<1%	5,953	$45K
87088		<1%	4,153	$45K
84146		<1%	3,411	$45K
86901		<1%	10,081	$43K
87536		<1%	570	$42K
86160		<1%	2,459	$42K
90480		<1%	1,092	$42K
85652		<1%	15,454	$38K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	2,474	$38K
0112A		<1%	843	$36K
82670		<1%	2,117	$34K
86900		<1%	10,151	$34K
0154A		<1%	775	$33K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	656	$33K
91321		<1%	820	$32K
0064A		<1%	806	$31K
83002		<1%	2,934	$31K
86769		<1%	752	$31K
83020		<1%	3,281	$29K
85610		<1%	7,923	$28K
86225		<1%	2,483	$28K
81003		<1%	13,407	$28K
82950		<1%	5,964	$28K
86147		<1%	649	$27K
87070		<1%	4,209	$26K
86696		<1%	1,235	$25K
86431		<1%	3,518	$24K
90686		<1%	1,345	$23K
86735		<1%	1,849	$23K
87493		<1%	527	$23K
86200		<1%	2,120	$22K
87338		<1%	1,162	$21K
87517		<1%	411	$21K
85046		<1%	3,930	$21K
83615		<1%	3,766	$20K
84270		<1%	1,276	$20K
84100		<1%	4,618	$20K
0074A		<1%	462	$19K
82533		<1%	1,506	$19K
86364		<1%	2,481	$19K
82627		<1%	1,437	$19K
82951		<1%	1,472	$18K
83516		<1%	1,534	$18K
86695		<1%	1,171	$18K
86334		<1%	803	$18K
86800		<1%	1,520	$17K
84550		<1%	4,332	$17K
83690		<1%	2,615	$17K
86376		<1%	1,929	$16K
84165		<1%	1,757	$16K
83525		<1%	1,735	$15K
86336		<1%	708	$15K
86665		<1%	428	$15K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	114	$15K
85730		<1%	2,689	$14K
82247		<1%	3,167	$14K
82550		<1%	2,508	$14K
0134A		<1%	364	$14K
82248		<1%	3,611	$14K
86765		<1%	1,726	$14K
88142		<1%	1,124	$14K
86300		<1%	558	$13K
84156		<1%	5,976	$13K
80197		<1%	1,385	$13K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	600	$13K
86039		<1%	1,237	$13K
83721		<1%	1,433	$13K
84144		<1%	671	$12K
82378		<1%	1,029	$12K
0053A		<1%	290	$12K
0121A		<1%	266	$11K
84305		<1%	741	$11K
83520		<1%	647	$11K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	32	$11K
85018		<1%	4,369	$10K
84460		<1%	2,054	$10K
84703		<1%	1,364	$10K
87449		<1%	634	$10K
82677		<1%	673	$9K
83521		<1%	573	$9K
82652		<1%	435	$9K
84450		<1%	1,991	$9K
86360		<1%	350	$9K
83498		<1%	556	$9K
84402		<1%	449	$8K
82565		<1%	1,911	$8K
87522	Neg quan hep c or qual rna	<1%	163	$8K
85379		<1%	1,103	$8K
82785		<1%	831	$8K
84445		<1%	255	$8K
84480		<1%	836	$8K
87075		<1%	617	$7K
0164A		<1%	166	$7K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	51	$7K
86304		<1%	344	$7K
85014		<1%	3,069	$7K
0081A		<1%	167	$7K
87045		<1%	583	$7K
85390		<1%	772	$7K
86705		<1%	471	$7K
87209		<1%	446	$7K
87427		<1%	539	$6K
0073A		<1%	153	$6K
85245		<1%	446	$6K
82150		<1%	1,023	$6K
82397		<1%	454	$6K
80177		<1%	691	$6K
82610		<1%	572	$6K
0003A		<1%	171	$6K
84425		<1%	474	$6K
86359		<1%	294	$6K
87205		<1%	1,683	$6K
81025		<1%	1,090	$6K
85613		<1%	716	$6K
82977		<1%	1,122	$6K
87521	Neg quan hep c or qual rna	<1%	131	$5K
0082A		<1%	131	$5K
82952		<1%	1,434	$5K
84681		<1%	448	$5K
83993		<1%	459	$5K
0151A		<1%	124	$5K
85732		<1%	730	$5K
86618		<1%	230	$5K
36415	Collection of venous blood by venipuncture	<1%	6,709	$5K
80164		<1%	568	$5K
85576		<1%	215	$5K
84520		<1%	1,343	$5K
80069		<1%	610	$4K
83014		<1%	557	$4K
84484		<1%	557	$4K
85246		<1%	285	$4K
87625		<1%	137	$4K
82390		<1%	446	$4K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	55	$4K
84466		<1%	434	$4K
84630		<1%	379	$4K
85670		<1%	790	$4K
87046		<1%	640	$4K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	69	$3K
86694		<1%	252	$3K
88304		<1%	163	$3K
87177		<1%	444	$3K
87497		<1%	78	$3K
82024		<1%	143	$3K
0083A		<1%	73	$3K
84432		<1%	182	$3K
86870		<1%	182	$3K
90656		<1%	131	$3K
82330		<1%	192	$2K
88230		<1%	25	$2K
86381		<1%	160	$2K
86593		<1%	565	$2K
71046	Radiologic examination, chest; 2 views	<1%	272	$2K
84155		<1%	664	$2K
82947		<1%	566	$2K
0141A		<1%	46	$2K
85240		<1%	160	$2K
86341		<1%	90	$2K
86141		<1%	110	$2K
86644		<1%	100	$2K
86708		<1%	186	$2K
85660		<1%	345	$2K
82140		<1%	191	$2K
87147		<1%	424	$1K
0142A		<1%	31	$1K
84244		<1%	61	$1K
86015		<1%	195	$1K
82088		<1%	32	$1K
82157		<1%	69	$1K
82340		<1%	225	$1K
84163		<1%	119	$1K
99000		<1%	43	$1K
87799		<1%	17	$972.79
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	76	$950.75
86361		<1%	61	$894.91
83718		<1%	118	$874.55
82747		<1%	62	$799.27
90662		<1%	23	$785.15
83630		<1%	66	$733.56
86258		<1%	78	$727.46
82465		<1%	165	$686.94
87102		<1%	105	$642.97
96127		<1%	36	$584.00
0013A		<1%	13	$547.82
93793		<1%	183	$515.70
86645		<1%	29	$509.92
87077		<1%	816	$481.45
85247		<1%	34	$480.98
86677		<1%	32	$450.75
84166		<1%	49	$448.38
83010		<1%	51	$436.42
82103		<1%	42	$353.21
85384		<1%	57	$349.71
86709		<1%	54	$343.16
82525		<1%	31	$326.63
80178		<1%	50	$318.50
84436		<1%	43	$271.62
84080		<1%	27	$270.53
82310		<1%	60	$246.48
82164		<1%	28	$242.14
84145		<1%	14	$228.62
73610		<1%	15	$228.06
77063	Screening digital breast tomosynthesis, bilateral	<1%	16	$197.54
87040		<1%	12	$189.00
82653		<1%	14	$179.14
84132		<1%	47	$170.71
83519		<1%	12	$169.09
87206		<1%	42	$168.39
86308		<1%	35	$168.00
83835		<1%	12	$158.16
85306		<1%	13	$119.40
85303		<1%	13	$118.03
86060		<1%	12	$103.20
80156		<1%	12	$93.84
87101		<1%	14	$86.80
G0008	Administration of influenza virus vaccine	<1%	12	$71.28
84075		<1%	13	$57.28
81002		<1%	15	$39.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.